healthcare

argenx to Present at TD Cowen 46th Annual Healthcare Conference

February 23, 2026 01:00 ET  | Source: argenx SE February 23, 2026Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX),…

2 weeks ago

Fractal launches Vaidya 2.0, outperforming leading frontier models on Healthcare AI Benchmarks

"Vaidya 2.0 is the first AI model to achieve a 50+ score on OpenAI's HealthBench (hard), outperforming GPT-5 and Google's…

3 weeks ago

Precise Bio to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

GREENSBORO, N.C., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Precise Bio, Inc. (“Precise Bio” or the “Company”), a clinical-stage regenerative medicine…

3 weeks ago

Hexaware and CareInsight Announce Strategic Partnership to Accelerate AI-driven Healthcare Transformation

MUMBAI, India, Feb. 12, 2026 /PRNewswire/ -- Hexaware Technologies (NSE: HEXT), a global provider of IT services and solutions, today…

4 weeks ago

Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference

Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong China market presenceNext-generation BTK protein degrader APG-3288 receives…

2 months ago

Firstsource Acquires TeleMedik To Bolster Digital Offerings and Expand Presence in U.S. Healthcare Payer and Provider Markets

MUMBAI, India and DALLAS, Jan. 13, 2026 /PRNewswire/ -- Firstsource Solutions Limited (NSE: FSL) (BSE: 532809), a leading global provider of…

2 months ago

NYSE Content Advisory: Pre-Market Update + NYSE Takes Its Bell on the Road to JPMorgan’s Healthcare Event

NEW YORK, Jan. 12, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

2 months ago

BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference

January 12, 2026 10:30 ET  | Source: BridgeBio Pharma, Inc. - Preliminary unaudited Q4 and Full Year 2025 net Attruby® product…

2 months ago

Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference

January 11, 2026 13:00 ET  | Source: Krystal Biotech, Inc. Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to…

2 months ago

Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference

- Rapidly transforming into a leading global biopharma company January 09, 2026 18:01 ET  | Source: Ascendis Pharma COPENHAGEN, Denmark,…

2 months ago